Integrating HIV-Related Evidence-Based Renal Care Guidelines Into Adult HIV Clinics

References 

1. AGREE Collaboration. Appraisal of guidelines for research & evaluation (AGREE) instrument. London, United Kingdom: St. George's University of London; 2001;
2. Arribas JR, Pozniak AL, Gallant JE, DeJesus E, Gazzard B, Campo RE, et al. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients. Journal of Acquired Immune Deficiency Syndromes. 2008;47:74–78
3. Centers for Disease Control and Prevention. Estimates of new HIV infection in the United States. CDC HIV/AIDS Facts. 2008;Retrieved from www.cdc.gov/hiv/topics/surveillance/resources/factsheets/incidence.htm
4. Centers for Disease Control and Prevention. (2008b). HIV/AIDS surveillance report, 2006. Retrieved from http://www.cdc.gov/hiv/topics/surveillance/resources/reports
5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult U.S. population: Third national health and nutrition examination survey. American Journal of Kidney Diseases. 2003;41:10–29
6. De Silva RI, Post FA, Griffin MD, Dockbell DH. HIV-1 infection and the kidney: An evolving challenge in HIV medicine. Mayo Clinic Proceedings. 2007;82:1103–1116
7. DiCenso A, Guyatt G, Ciliska D. Evidence-based nursing: A guide to clinical practice. St. Louis, MO: Elsevier Mosby; 2005;
8. Gawlinski A. Evidence-based practice changes: Measuring the outcome. AACN Advanced Critical Care. 2007;18:320–322
   • CrossRef
9. Gebo KA. HIV and aging: Implications for management. Drugs and Aging. 2006;23:897–913
10. Gray M, Huether SE, Forshee BA. Alterations of renal and urinary tract function. In:  McCance KL,  Huether SE editor. Pathophysiology: The biologic basis for disease in adults and children. 5th ed. St. Louis, MO: Elsiever Mosby; 2006;p. 1301–1335
11. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2005;40:1559–1585
12. Heffelfinger, J., Hanson, D., Voetsch, A., McNaghten, A., & Sullivan, P. (2006). Renal impairment associated with use of tenofovir (Abstract No. 779). Paper presented at the 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO.
13. Jacobson, L. P., Margolick, J., Bolan, R., Phair, J., Palella, F. J., & Study, M. A. C. (2007). Proteinuria among HIV-infected HAART recipients in the multicenter AIDS cohort study (Abstract No. CDB328). Paper presented at the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia.
14. Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. American Family Physician. 2004;70:869–876
    • MEDLINE
15. Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers. American Family Physician. 2004;70:1091–1097
    • MEDLINE
16. Kalayjin RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, et al. Suppression of HIV-1 replication by antiretroviral therapy improved renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS. 2008;22:481–487
    • CrossRef
17. Kiser JJ, Carten ML, Aquilante CL, Anderson PL, Wolfe P, King TM, et al. The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients. Clinical Pharmacology and Therapeutics. 2008;83:265–272
    • CrossRef
18. Kleber M, Cybulla M, Bauchmuller K, Ihorst G, Koch G, Engelhardt M. Monitoring of renal function in cancer patients: An ongoing challenge for clinical practice. Annals of Oncology. 2007;18:950–958
19. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Annals of Internal Medicine. 2003;139:137–147
20. Novoa AM, De Olalla PG, Clos R, Orcau A, Rodriguez-Sanz M, Cayla J. Increase in the non-HIV-related deaths among AIDS cases in the HAART era. Current HIV Research. 2008;6:77–81
    • CrossRef
21. Pender NJ, Murdaugh CL, Parsons MA. Health promotion in nursing practice. 5th ed.. Upper Saddle River, NJ: Pearson Prentice Hall; 2006;
22. Redman B. The practice of patient education. 10th ed.. St. Louis, MO: Mosby; 2006;
23. Rogers EM. Diffusion of innovation. 5th ed.. New York, NY: Free Press; 2003;
24. Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. The Journal of Infectious Diseases. 2008;197:1133–1144
    • CrossRef
25. Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der Horst C, Sidney S, et al. Microalbuminuria in HIV-infection. AIDS. 2007;21:1003–1009
    • MEDLINE
26. Winston JA. Assessing kidney function in HIV-infection. AIDS Reader. 2007;17:257–264
27. Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Kidney disease in patients with HIV infection and AIDS. Clinical Infectious Diseases. 2008;47:1449–1457